Fingerprint
Dive into the research topics of 'Phase II Study of Irinotecan Plus Panitumumab as Second-Line Therapy for Patients with Advanced Esophageal Adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Harry Yoon, Lilit Karapetyan, Anita Choudhary, Ramla Kosozi, Gurvinder Singh Bali, Ali H. Zaidi, Ajlan Atasoy, Arlene A. Forastiere, Michael K. Gibson
Research output: Contribution to journal › Article › peer-review